Eye photos for diabetes patients
Part of Eyes & vision, Heart & circulation, Hormones & metabolism clinical trials.
This trial takes colored photos of the back of your eye to help experts identify diabetes-related changes. It may help detect eye problems early in people with diabetes.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have type 1 or type 2 diabetes.
- You are 20 years old or older.
- You are able and willing to follow the study steps.
- You are not in prison or legally detained.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study uses a special eye imaging test called OCT angiography to look at tiny blood vessels in the back of the eye. It aims to understand changes caused by diabetic retinopathy, which could help improve how we monitor and treat this condition.
This study tests an AI platform that checks for diabetic retinopathy, a common eye problem in people with diabetes. It aims to see if the AI can spot signs of damage early, so you can get treatment sooner.
This trial tests whether an artificial intelligence (AI) system can help doctors diagnose diabetic retinopathy, an eye condition caused by diabetes. If you have diabetes and haven't been treated for it yet, you may be able to join.
This study looks for specific eye findings (“biomarkers”) in people with type 2 diabetes using eye imaging. It may help researchers better understand diabetic retinopathy and how to detect it earlier or more accurately.
This study tests an AI system that automatically detects signs of diabetic retinopathy from eye photos. It aims to see if the AI can accurately identify these signs to help with early detection.
This study tests whether advanced eye imaging can predict how diabetic eye disease (retinopathy) may worsen over time. If you have type 2 diabetes and early to moderate diabetic retinopathy without swelling in the central part of the retina, you may be able to join.
Hear when a new Retinal Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.